Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck.

Trial Profile

Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Jul 2013

At a glance

  • Drugs Docetaxel (Primary) ; Oxaliplatin (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2012 Actual end date (1 Jul 2010) added as reported by ClinicalTrials.gov.
    • 31 Mar 2011 Planned end date [Jan 2012] added as reported by ClinicalTrials.gov.
    • 31 Mar 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top